US Bancorp’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $19.8K | Sell |
2,106
-11,064
| -84% | -$99.1K | ﹤0.01% | 3204 |
|
|
2026
Q1 | $107K | Buy |
13,170
+257
| +2% | +$2.33K | ﹤0.01% | 2348 |
|
|
2025
Q4 | $86.8K | Sell |
12,913
-419
| -3% | -$3.16K | ﹤0.01% | 2448 |
|
|
2025
Q3 | $116K | Sell |
13,332
-1,152
| -8% | -$8.97K | ﹤0.01% | 2282 |
|
|
2025
Q2 | $91.2K | Buy |
14,484
+2,433
| +20% | +$16.1K | ﹤0.01% | 2464 |
|
|
2025
Q1 | $77.2K | Buy |
12,051
+245
| +2% | +$2.02K | ﹤0.01% | 2522 |
|
|
2024
Q4 | $94.9K | Sell |
11,806
-493
| -4% | -$4.75K | ﹤0.01% | 2418 |
|
|
2024
Q3 | $155K | Buy |
12,299
+11,961
| +3,539% | +$154K | ﹤0.01% | 2171 |
|
|
2024
Q2 | $4.28K | Sell |
338
-1,480
| -81% | -$14.9K | ﹤0.01% | 3563 |
|
|
2024
Q1 | $8.69K | Buy |
1,818
+623
| +52% | +$2.89K | ﹤0.01% | 3375 |
|
|
2023
Q4 | $5.74K | Sell |
1,195
-4,726
| -80% | -$28.9K | ﹤0.01% | 3483 |
|
|
2023
Q3 | $42.9K | Sell |
5,921
-2,645
| -31% | -$21.1K | ﹤0.01% | 2517 |
|
|
2023
Q2 | $63.6K | Buy |
8,566
+3,626
| +73% | +$28.5K | ﹤0.01% | 2396 |
|
|
2023
Q1 | $34.2K | Buy |
4,940
+2,755
| +126% | +$25.3K | ﹤0.01% | 2711 |
|
|
2022
Q4 | $22.5K | Sell |
2,185
-469
| -18% | -$8.28K | ﹤0.01% | 2943 |
|
|
2022
Q3 | $49K | Buy |
2,654
+384
| +17% | +$16.6K | ﹤0.01% | 2550 |
|
|
2022
Q2 | $117K | Buy |
2,270
+187
| +9% | +$9.69K | ﹤0.01% | 2159 |
|
|
2022
Q1 | $154K | Buy |
2,083
+614
| +42% | +$54.8K | ﹤0.01% | 2079 |
|
|
2021
Q4 | $211K | Sell |
1,469
-556
| -27% | -$95.5K | ﹤0.01% | 1953 |
|
|
2021
Q3 | $419K | Sell |
2,025
-93
| -4% | -$20.5K | ﹤0.01% | 1612 |
|
|
2021
Q2 | $449K | Sell |
2,118
-2,730
| -56% | -$500K | ﹤0.01% | 1603 |
|
|
2021
Q1 | $879K | Sell |
4,848
-1,858
| -28% | -$370K | ﹤0.01% | 1200 |
|
|
2020
Q4 | $748K | Buy |
6,706
+1,032
| +18% | +$110K | ﹤0.01% | 1237 |
|
|
2020
Q3 | $615K | Buy |
5,674
+2,017
| +55% | +$246K | ﹤0.01% | 1223 |
|
|
2020
Q2 | $305K | Buy |
3,657
+3,257
| +814% | +$125K | ﹤0.01% | 1553 |
|
|
2020
Q1 | $5K | Buy |
+400
| New | +$3.38K | ﹤0.01% | 3262 |
|
|
2016
Q4 | – | Sell |
-45
| Closed | -$2K | – | 3606 |
|
|
2016
Q3 | $2K | Hold |
45
| – | – | ﹤0.01% | 3364 |
|
|
2016
Q2 | $7K | Hold |
45
| – | – | ﹤0.01% | 3092 |
|
|
2016
Q1 | $5K | Hold |
45
| – | – | ﹤0.01% | 3169 |
|
|
2015
Q4 | $8K | Hold |
45
| – | – | ﹤0.01% | 3111 |
|
|
2015
Q3 | $6K | Sell |
45
-44
| -49% | -$9.87K | ﹤0.01% | 3210 |
|
|
2015
Q2 | $20K | Sell |
89
-131
| -60% | -$23K | ﹤0.01% | 2940 |
|
|
2015
Q1 | $36K | Hold |
220
| – | – | ﹤0.01% | 2702 |
|
|
2014
Q4 | $26K | Sell |
220
-98
| -31% | -$10.2K | ﹤0.01% | 2795 |
|
|
2014
Q3 | $26K | Hold |
318
| – | – | ﹤0.01% | 2771 |
|
|
2014
Q2 | $29K | Hold |
318
| – | – | ﹤0.01% | 2714 |
|
|
2014
Q1 | $29K | Sell |
318
-156
| -33% | -$17.4K | ﹤0.01% | 2693 |
|
|
2013
Q4 | $49K | Sell |
474
-152
| -24% | -$10.7K | ﹤0.01% | 2422 |
|
|
2013
Q3 | $39K | Hold |
626
| – | – | ﹤0.01% | 2430 |
|
|
2013
Q2 | $26K | Buy |
+626
| New | +$27.1K | ﹤0.01% | 2559 |
|
Other funds holding NVAX
SCM
S
US Bancorp's NVAX Position: Q2 2026 in Review
US Bancorp reduced its Novavax (NVAX) stake by 84% in Q2 2026, selling an estimated $99.1K and leaving 2,106 shares worth $19.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3204.
US Bancorp first reported a position in NVAX in Q2 2013 and has held it in 40 quarters since. The position peaked at $879K in Q1 2021. 266 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.
- US Bancorp held 2,106 shares of Novavax worth $19.8K as of Q2 2026.
- US Bancorp sold 11,064 Novavax shares in Q2 2026, an estimated $99.1K.
- Novavax made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #3204 holding.
- US Bancorp first reported a position in Novavax in Q2 2013 and has held it in 40 quarters since.
- US Bancorp's Novavax position peaked at $879K in Q1 2021.
- 266 funds tracked by Wall St. Rank held Novavax as of Q2 2026.
Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.